Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
Linda Wong, Kliment Bozhilov, Brenda Hernandez, Sandi Kwee, Owen Chan, Luke Ellis, Loic LeMarchand
Clin Mol Hepatol. 2019;25(3):305-316.   Published online 2019 Apr 19     DOI: https://doi.org/10.3350/cmh.2019.0004
Citations to this article as recorded by Crossref logo
Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives
Ke-Yu Shen, Ying Zhu, Sun-Zhe Xie, Lun-Xiu Qin
Journal of Hematology & Oncology.2024;[Epub]     CrossRef
Establishment and Validation of Nomogram for Predicting Early Postoperative Recurrence of Liver Cancer
永辉 马
Advances in Clinical Medicine.2024; 14(03): 1859.     CrossRef
The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors
Lin Qin
Discover Oncology.2024;[Epub]     CrossRef
Correlation of Prognostic Nutritional Index and Systemic Immune-Inflammation Index with the Recurrence and Prognosis in Oral Squamous Cell Carcinoma with the Stage of III/IV
Manjun Ye, Lixia Zhang
International Journal of General Medicine.2024; Volume 17: 2289.     CrossRef
Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD
Devaraj Ezhilarasan, Kulanthaivel Langeswaran
Cell Biochemistry and Function.2024;[Epub]     CrossRef
Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets
Liu Yang, Yawen Hao, Joost Boeckmans, Robim M. Rodrigues, Yong He
Pharmacology & Therapeutics.2023; 243: 108353.     CrossRef
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani
Biomedicines.2023; 11(2): 586.     CrossRef
Human microbiomes in cancer development and therapy
Chenglai Xia, Jiyan Su, Can Liu, Zhikai Mai, Shuanghong Yin, Chuansheng Yang, Liwu Fu
MedComm.2023;[Epub]     CrossRef
Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study
Rongqiang Liu, Shinan Wu, Hao yuan Yu, Kaining Zeng, Zhixing Liang, Siqi Li, Yongwei Hu, Yang Yang, Linsen Ye
Heliyon.2023; 9(11): e22458.     CrossRef
High Neutrophil–Lymphocyte Ratio and Delta Neutrophil–Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer
Nicole E. Rich, Aarthi Parvathaneni, Ahana Sen, Mobolaji Odewole, Ana Arroyo, Arjmand R. Mufti, Thomas A. Kerr, Lafaine Grant, Shannan R. Tujios, Marlyn J. Mayo, William M. Lee, Ju Dong Yang, Takeshi Yokoo, Purva Gopal, Yujin Hoshida, Hao Zhu, Adam C. Yop
Digestive Diseases and Sciences.2022; 67(6): 2666.     CrossRef
Application of Serum Biomarkers in Early Diagnosis and Prognosis of Hepatocellular Carcinoma
佳骏 芦
Advances in Clinical Medicine.2022; 12(06): 5446.     CrossRef
Prognostic Nutritional Index and Neutrophil/Lymphocyte Ratio Can Serve as Independent Predictors of the Prognosis of Hepatocellular Carcinoma Patients Receiving Targeted Therapy
Wei Chen, Mingjun Zhang, Chanjuan Chen, Xiaonan Pang, Jinghua Pan
Journal of Oncology.2022; 2022: 1.     CrossRef
Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer
Li-ting Wang, Qiu-ling Zeng, Shao-lan Jiang, Zhen-yu Chen, Xiao-ling Wang, Ling Li, Xiaolong Li
Frontiers in Oncology.2022;[Epub]     CrossRef
Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article
Mohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio
Annals of Hepatology.2021; 22: 100249.     CrossRef
Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: A systematic review and meta‐analysis
Han Ah Lee, Sunmin Park, Yeon Seok Seo, Won Sup Yoon, In‐Soo Shin, Chai Hong Rim
Journal of Hepato-Biliary-Pancreatic Sciences.2021; 28(12): 1031.     CrossRef
Tannins inTerminalia belliricainhibit hepatocellular carcinoma growth by regulating EGFR-signaling and tumor immunity
Zihao Chang, Ping Jian, Qiunan Zhang, Wenyi Liang, Kun Zhou, Qian Hu, Yuqi Liu, Runping Liu, Lanzhen Zhang
Food & Function.2021; 12(8): 3720.     CrossRef
Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque
Frontiers in Medicine.2021;[Epub]     CrossRef
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123.     CrossRef
Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study
Young Youn Cho, Su Jong Yu, Hye Won Lee, Do Young Kim, Wonseok Kang, Yong-Han Paik, Pil Soo Sung, Si Hyun Bae, Su Cheol Park, Young Seok Doh, Kang Mo Kim, Eun Sun Jang, In Hee Kim, Won Kim, Yoon Jun Kim
Journal of Hepatocellular Carcinoma.2021; Volume 8: 613.     CrossRef
Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma
Han Ah Lee, Hyun Gil Goh, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Min-Goo Lee, Hyunggin An, Yoon Tae Jeen, Jong Eun Yeon, Kwan Soo Byun, Yeon Seok Seo
BMC Gastroenterology.2021;[Epub]     CrossRef
Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
Soon Kyu Lee, Sung Won Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
International Journal of Molecular Sciences.2021; 22(19): 10271.     CrossRef
Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy
Hai-Bin Tu, Li-Hong Chen, Yu-Jie Huang, Si-Yi Feng, Jian-Ling Lin, Yong-Yi Zeng
World Journal of Clinical Cases.2021; 9(24): 7009.     CrossRef
Cellular based immunotherapy for primary liver cancer
Yuanyuan Zheng, Yan Li, Jiao Feng, Jingjing Li, Jie Ji, Liwei Wu, Qiang Yu, Weiqi Dai, Jianye Wu, Yingqun Zhou, Chuanyong Guo
Journal of Experimental & Clinical Cancer Research.2021;[Epub]     CrossRef
Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review
Ayman Bannaga, Ramesh P Arasaradnam
World Journal of Gastroenterology.2020; 26(33): 5022.     CrossRef
A novel predictive model based on inflammatory markers to assess the prognosis of patients with HBV-related acute-on-chronic liver failure: a retrospective cohort study
Li Qiang, Jiao Qin, Changfeng Sun, Yunjian Sheng, Wen Chen, Bangdong Qiu, Xin Chen, Yuanfang Chen, Fei Liu, Gang Wu
BMC Gastroenterology.2020;[Epub]     CrossRef